Policy Topics | Policy Briefings

Biotechnology

The federal government has already successfully supported projects that are adding capacity across a range of vaccine and therapeutic platforms and production processes, such as RNA, protein-based and viral vector vaccine development and production, says Liberal MP Andy Fillmore. Photograph courtesy of Pexels

MOST RECENT POLICY BRIEFINGS

Upcoming Policy briefings

See all upcoming 2022 Hill Times Policy Briefings

Exclusive lists